Associate Director, Program Management — Asset Diligence & Integration

Confirmed live in the last 24 hours

Formation Bio

New York, NY; Boston, MA

Hybrid

Posted March 30, 2026

Job Description

About Formation Bio

Formation Bio is a tech and AI driven pharma company differentiated by radically more efficient drug development.

Advancements in AI and drug discovery are creating more candidate drugs than the industry can progress because of the high cost and time of clinical trials. Recognizing that this development bottleneck may ultimately limit the number of new medicines that can reach patients, Formation Bio, founded in 2016 as TrialSpark Inc., has built technology platforms, processes, and capabilities to accelerate all aspects of drug development and clinical trials. Formation Bio partners, acquires, or in-licenses drugs from pharma companies, research organizations, and biotechs to develop programs past clinical proof of concept and beyond, ultimately helping to bring new medicines to patients. The company is backed by investors across pharma and tech, including a16z, Sequoia, Sanofi, Thrive Capital, Sam Altman, John Doerr, Spark Capital, SV Angel Growth, and others.

You can read more at the following links:

At Formation Bio, our values are the driving force behind our mission to revolutionize the pharma industry. Every team and individual at the company shares these same values, and every team and individual plays a key part in our mission to bring new treatments to patients faster and more efficiently.

About the Position

Formation Bio is seeking an Associate Director, Program Management - Asset Diligence & Integration to partner with our Business Development (BD) and cross-functional teams across the end-to-end asset diligence lifecycle—from initial screen through confirmatory diligence and integration. This role will lead late-stage diligence efforts, support asset onboarding post-acquisition, and help build scalable program management infrastructure that enhances execution, visibility, and governance.

Depending on portfolio needs, you may also flex into post-acquisition program management, driving near-term development milestones until steady-state ownership is established.

Key Responsibilities

Diligence Program Management

Lead and manage the full diligence process from initial evaluation to pre-close.
Coordinate cross-functional workstreams (Clinical, CMC, Regulatory, Nonclinical, QA, Commercial, Finance, Legal/IP).
Maintain trackers, RAID logs, and timelines; deliver leadership updates and red-flag summaries.
Orchestrate expert calls, debriefs, and management meetings, capturing insights and follow-ups.

Confirmatory Diligence Leadership

Drive scientific, technical, and commercial deep dives across functions.
Lead scenario planning for timelines, costs, and resources; partner with Finance to assess trade-offs and business impact.
Prepare executive-ready Go/No-Go materials outlining risks, mitigations, and term-sheet implications.

Program Management Infrastructure & Process Optimization

Build and refine playbooks, templates, and decision-making frameworks for diligence and integration.
Enhance Smartsheet-based dashboards, workflows, and reporting tools for portfolio governance.
Identify and implement AI and automation tools to streamline workflows and accelerate decision-making.
Drive cross-functional planning, risk management, and clear action tracking.

Flex Capacity (Post-Acquisition Support)